Friedman, Kevin
Mayo Clinic
From the Massachusetts General Hospital Cancer Center (N.R., M.V.M.), Beth Israel Deaconess Medical Center (J.R.), and Dana-Farber Cancer Institute and Veterans Affairs Boston Healthcare System (N.M.), Boston, and Bluebird Bio, Cambridge (A.T., L.-P.L., R.
Citations 1
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
Lin, Yi , Siegel, David S. , Madduri, Deepu , Liedtke, Michaela , Rosenblatt, Jacalyn , Turka, Ashley, Lam, Lyh-Ping, Morgan, Richard A. , Friedman, Kevin M., Massaro, Monica, Russotti, Greg, Yang, Zhihong, Campbell, Timothy , Hege, Kristen , Petrocca, Fabio , Quigley, M. Travis, Munshi, Nikhil C. , Kochenderfer, James N. , Berdeja, Jesús, Siegel, David , Maus, Marcela V., Friedman, Kevin, Wang, Julie, Munshi, Nikhil , Lin, Yi , Raje, Noopur , Berdeja, Jesús G. , Jagannath, Sundar , Maus, Marcela V , Lam, Lyh Ping, Wang, Julie , Petrocca, Fabio
New England Journal of Medicine | May 1, 2019 | Volume: 380 | Issue: 18 | Pages: 1726-1737
